Vascular Surgery
Abdominal Aortic Aneurysm
Manage abdominal aortic aneurysm by separating suspected rupture from stable disease, confirming maximal diameter with appropriate imaging, matching surveillance to size and sex, and referring for repair when symptoms, rapid expansion, or rupture-risk thresholds outweigh procedural risk.
Emergency Decision
When suspected AAA requires immediate operative evaluation
Do not use aneurysm diameter to defer action in a symptomatic patient.
In a patient with abdominal and/or back pain, hypotension, and a pulsatile abdominal mass, obtain immediate surgical evaluation for suspected ruptured AAA. This triad is a Class I indication for immediate evaluation; rupture is associated with substantial prehospital mortality, with approximately 60% of patients dying before hospital arrival in one cited U.S. summary. jacc+1jaccManagement of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelinescdn clinicaltrialsNoninvasive Assessment of Abdominal Aortic Aneurysm
A symptomatic aortic aneurysm warrants repair regardless of measured diameter. Symptoms or hemodynamic instability therefore override surveillance schedules and elective size thresholds; involve vascular surgery immediately while diagnostic imaging is pursued only when it will not delay definitive management. jaccjaccManagement of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
For a stable patient in whom AAA anatomy must be defined for intervention, CT, angiography, and ultrasound can establish aneurysm presence, location, shape, and size. Ultrasound is rapid for identifying AAA but may be limited by obesity or overlying bowel gas; use cross-sectional imaging when ultrasound is nondiagnostic or detailed anatomic planning is needed. accessdata fda+1accessdata fda[PDF] ENDNGX - accessdata.fda.govjacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Immediate escalation trigger: abdominal or back pain plus hypotension and a pulsatile mass. jaccjaccManagement of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Do not observe a symptomatic AAA solely because it is below 5.0 or 5.5 cm. jaccjaccManagement of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
If stable and planning repair, obtain imaging that defines aneurysm morphology and access anatomy. accessdata fdaaccessdata fda[PDF] ENDNGX - accessdata.fda.gov
Diagnostic Pathway
Confirm AAA and establish the measurement that drives follow-up
Use a reproducible maximal diameter before assigning surveillance or repair.
Diagnose AAA by abdominal ultrasound when the aortic diameter is greater than 3.0 cm, measured primarily outer edge to outer edge in the anterior-posterior or transverse plane. Ultrasound is the recommended screening and surveillance modality, with sensitivity approaching 100% for aneurysm detection, although image quality is reduced by obesity and bowel gas. jaccjacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
An aortic diameter greater than 3 cm on screening should trigger enrollment in a surveillance imaging program rather than dismissal as an incidental finding. Maximum diameter is the dominant rupture-risk discriminator, and rupture risk rises as aneurysms exceed 5.5 cm in men and 5.0 cm in women. spj science+1spj scienceComprehensive bioinformatics analysis revealed potential key ...jacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Use CT or other anatomic imaging when repair is under consideration or when ultrasound cannot adequately define the aneurysm. Imaging before intervention must establish location, shape, size, and anatomic suitability for endovascular versus open repair. accessdata fda+1accessdata fda[PDF] ENDNGX - accessdata.fda.govcdn clinicaltrials[PDF] Title Page: - ClinicalTrials.gov
AAA definition for ultrasound surveillance: diameter greater than 3.0 cm. jaccjacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Measurement convention: outer-edge-to-outer-edge diameter in anterior-posterior or transverse view. jaccjacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Ultrasound limitation: nondiagnostic examinations can occur with obesity or superimposed bowel gas. jaccjacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Stable Disease
Surveil small asymptomatic AAA and act on expansion or symptoms
Surveillance is appropriate when rupture risk remains lower than intervention risk.
For asymptomatic small AAA, surveillance rather than early repair is appropriate because the rupture risk below 5 cm is low; one guideline summary supports observation to 5.5 cm unless symptoms or rapid expansion occur. Rapid expansion greater than 1 cm/year should prompt reassessment for repair even if the aneurysm remains below the usual diameter threshold. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
Use ultrasound surveillance every 2 to 3 years for AAAs smaller than 4.0 cm. For AAAs measuring 4.0 to 5.4 cm, monitor by ultrasound or CT every 6 to 12 months to detect expansion. As diameter approaches the sex-specific repair threshold, surveillance should become more frequent because rupture risk increases with size. jacc+1jacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesjaccManagement of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
For patients managed nonoperatively, address modifiable cardiovascular risk with smoking cessation and blood-pressure management. These measures are specifically recommended for asymptomatic patients who do not yet meet intervention criteria. spj sciencespj scienceComprehensive bioinformatics analysis revealed potential key ...
Escalate to repair evaluation for symptoms or expansion greater than 1 cm/year. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
At each surveillance visit, address smoking cessation and blood-pressure management. spj sciencespj scienceComprehensive bioinformatics analysis revealed potential key ...
Procedure Selection
Choose EVAR or open repair by anatomy, operative risk, and durability priorities
Both repair strategies prevent rupture; their early and late tradeoffs differ.
Elective repair is generally recommended for men with AAA greater than 5.5 cm and women with AAA greater than 5.0 cm. Aneurysm symptoms and rapid expansion can justify repair earlier, whereas anatomic feasibility, age, operative risk, and patient preferences should determine whether EVAR or open repair is used. fda+3fda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...spj scienceComprehensive bioinformatics analysis revealed potential key ...jacc2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelinescdn clinicaltrials[PDF] Title Page: - ClinicalTrials.gov
EVAR provides lower perioperative mortality than open repair and is associated with shorter operative time, less blood loss, fewer major operative complications, shorter hospitalization, more rapid recovery, and potential avoidance of intensive care or use of local anesthesia in selected patients. These early advantages make EVAR attractive when anatomy is suitable and perioperative risk reduction is a major priority. fda+3fda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...NEJMOpen versus Endovascular Repair of Abdominal Aortic AneurysmNEJMA Randomized Trial Comparing Conventional and Endovascular ...NEJMEndovascular vs. Open Repair of Abdominal Aortic Aneurysms in ...
Open repair offers a different durability profile. Compared with open repair, EVAR has higher reintervention rates related to endoleak, graft patency problems, aneurysm sac expansion, device migration, and device failure; EVAR also requires long-term imaging that exposes patients to radiation and intravenous contrast when CT is used. Discuss these surveillance and reintervention commitments before selecting EVAR. fda+2fda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...NEJMLong-Term Outcome of Open or Endovascular Repair of Abdominal ...cdn clinicaltrials[PDF] Title Page: - ClinicalTrials.gov
Do not assume that EVAR improves survival in every patient considered unfit for open surgery. The decision to intervene in a high-risk patient should still account for life expectancy, aneurysm rupture risk, procedural risk, and whether the anatomy permits a durable repair. The Lancet+1The LancetEndovascular aneurysm repair and outcome in patients unfit for ...cdn clinicaltrials[PDF] Title Page: - ClinicalTrials.gov
Favor EVAR when suitable anatomy and reduced perioperative burden are priorities. fda+2fda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...NEJMOpen versus Endovascular Repair of Abdominal Aortic AneurysmNEJMEndovascular vs. Open Repair of Abdominal Aortic Aneurysms in ...
Favor consideration of open repair when long-term durability and avoidance of EVAR-specific device surveillance are central concerns. fda+1fda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...NEJMLong-Term Outcome of Open or Endovascular Repair of Abdominal ...
Before either approach, define anatomy and incorporate age, surgical risk, and patient preference. cdn clinicaltrialscdn clinicaltrials[PDF] Title Page: - ClinicalTrials.gov
Counseling points before elective repair
Explain that EVAR offers an early perioperative advantage but transfers risk into mandatory late surveillance and potential secondary procedures. Conversely, open repair carries greater initial operative burden but avoids the EVAR-specific risks of endoleak, migration, and sac expansion that drive reintervention. fda+3fda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...NEJMOpen versus Endovascular Repair of Abdominal Aortic AneurysmNEJMLong-Term Outcome of Open or Endovascular Repair of Abdominal ...NEJMEndovascular vs. Open Repair of Abdominal Aortic Aneurysms in ...
EVAR-specific late failure targets: endoleak, sac growth, device migration, patency failure, and device failure. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
EVAR follow-up may require CT-associated radiation and intravenous contrast exposure. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
After EVAR
Detect endoleak, sac growth, migration, and device failure before rupture
Post-EVAR surveillance is a core component of the repair, not an optional follow-up step.
The purpose of post-EVAR imaging is to identify aneurysm sac growth, endoleak, device migration, patency problems, or other device failure before late rupture or aneurysm-related death. EVAR therefore obligates long-term imaging surveillance, unlike a one-time procedural episode. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
Obtain CT imaging at 1 month after EVAR. Concerning findings should prompt additional surveillance at 6 months; in the absence of concerning findings, continue annual duplex ultrasound. A new endoleak or aneurysm sac enlargement on duplex requires further imaging assessment and vascular surgery review. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
When counseling a patient who may have limited ability to adhere to serial imaging, include this requirement in procedural selection. The late safety advantage of surveillance depends on recognizing sac expansion or graft-related failure before rupture. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
CT at 1 month after EVAR. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
If the 1-month study is concerning, repeat surveillance at 6 months. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
Annual duplex ultrasound thereafter when no concerning findings are present. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
New endoleak or sac enlargement requires renewed evaluation rather than routine annual follow-up alone. fdafda[PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ...
References
- [PDF] FDA Executive Summary Circulatory System Devices Panel Meeting ... — www.fda.gov · www.fda.gov
- [PDF] ENDNGX - accessdata.fda.gov — www.accessdata.fda.gov · www.accessdata.fda.gov
- Family screening for abdominal aortic aneurysms - The Lancet — www.thelancet.com · www.thelancet.com
- Morphological suitability for endovascular repair, non-intervention ... — www.thelancet.com · www.thelancet.com
- Abdominal aortic aneurysm - The Lancet — www.thelancet.com · www.thelancet.com
- Open versus Endovascular Repair of Abdominal Aortic Aneurysm — www.nejm.org · www.nejm.org
- A Randomized Trial Comparing Conventional and Endovascular ... — www.nejm.org · www.nejm.org
- Long-Term Outcome of Open or Endovascular Repair of Abdominal ... — www.nejm.org · www.nejm.org
- Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in ... — www.nejm.org · www.nejm.org
- Endovascular aneurysm repair and outcome in patients unfit for ... — www.thelancet.com · www.thelancet.com
- An ultrasmall theranostic nanozyme for abdominal aortic aneurysm ... — www.science.org · www.science.org
- Comprehensive bioinformatics analysis revealed potential key ... — spj.science.org · spj.science.org
- Repair of Abdominal Aortic Aneurysms: JACC Focus Seminar, Part 1 — www.jacc.org · www.jacc.org
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines — www.jacc.org · www.jacc.org
- 2022 ACC/AHA Guideline for the Diagnosis and Management of ... — www.ahajournals.org · www.ahajournals.org
- Risk Factors for Abdominal Aortic Aneurysms in Older Adults ... — www.ahajournals.org · www.ahajournals.org
- Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines — www.jacc.org · www.jacc.org
- Medical Management of Small Abdominal Aortic Aneurysms — www.ahajournals.org · www.ahajournals.org
- Endovascular Abdominal Aortic Aneurysm Repair | Circulation — www.ahajournals.org · www.ahajournals.org
- Pathogenesis and management of abdominal aortic aneurysm — academic.oup.com · academic.oup.com
- [PDF] Title Page: - ClinicalTrials.gov — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
- [PDF] Untitled - ClinicalTrials.gov — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
- Noninvasive Assessment of Abdominal Aortic Aneurysm — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
- [PDF] Ovation Alto™ Abdominal Stent Graft System - ClinicalTrials.gov — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov